JD Health International Inc.
6618
株式のランク
#1466
JD Health International Inc., functioning as an investment holding entity, runs... JD Health International Inc., functioning as an investment holding entity, runs an expansive digital healthcare platform across the People's Republic of China. The company supplies a diverse range of pharmaceutical and wellness products, such as over-the-counter and prescription medications, medical devices, and health supplements. These goods are distributed through both direct sales and an extensive online retail pharmacy network. Beyond product offerings, its comprehensive service suite includes virtual medical consultations, patient referrals to hospitals and doctors, health screening programs, genetic testing, and beauty care services. Additionally, it develops intelligent healthcare and wellness management solutions, alongside providing technical support and advertising services. The platform also facilitates access to various medical provisions, including general health examinations, cosmetic medical procedures, vaccination bookings, dental treatments, and nucleic acid testing. Incorporated in 2018 and headquartered in Beijing, People's Republic of China, JD Health International Inc. is a subsidiary of JD Jiankang Limited.
株価
$4.93
時価総額
$15.74B
変化（1日）
-0.57%
変化（1年）
-38.03%
国
CN
取引 JD Health International Inc. (6618)
カテゴリー
Healthcare
JD Health International Inc.（6618）の収益
Jun 2026 時点の収益 TTM: $11.37B
JD Health International Inc. の最新の財務報告によると、現在の収益 (TTM) は $11.37B です。2023 年には $7.56B の収益があり、これは 2022 年の $6.78B と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
JD Health International Inc. の収益履歴（2017 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $11.37B | 42.72% |
| 2024 | $7.97B | 5.37% |
| 2023 | $7.56B | 11.61% |
| 2022 | $6.78B | 40.35% |
| 2021 | $4.83B | 62.70% |
| 2020 | $2.97B | 90.55% |
| 2019 | $1.56B | 31.11% |
| 2018 | $1.19B | 39.14% |
| 2017 | $853.51M | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $78.01B | 586.00% |
US
|
|
| - | - |
DE
|
|
| $21.81B | 91.80% |
US
|
|
| $3.89B | -65.75% |
SA
|
|
| $11.08B | -2.53% |
BR
|
